Opiate analgesics such as morphine are often used for pain therapy. However, antinociceptive tolerance and dependence may develop with long-term use of these drugs. It was found that μ-opioid receptors can interact with δ-opioid receptors, and morphine antinociceptive tolerance can be reduced by blocking δ-opioid receptors. Recent studies have shown that μ-and δ-opioid receptors are co-expressed in a considerable number of small neurons in the dorsal root ganglion. The interaction of μ-opioid receptors with δ-opioid receptors in the nociceptive afferents is facilitated by the stimulus-induced cell-surface expression of δ-opioid receptors, and contributes to morphine tolerance. Further analysis of the molecular, cellular and neural circuit mechanisms that regulate the trafficking and interaction of opioid receptors and related signalling molecules in the pain pathway would help to elucidate the mechanism of opiate analgesia and improve pain therapy.
LINKED ARTICLESThis article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2 Abbreviations CGRP, calcitonin gene-related peptide; DOPr-eGFP, δ-opioid receptors inserted with the enhanced green fluorescent protein at the C-terminus; DAMGO, Tyr-D-Ala-Gly-MePhe-Gly-ol; DRG, dorsal root ganglion; HA, haemagglutinin; IB4, isolectin B4; LDCV, large dense-core vesicle; PC12 cell, phaeochromocytoma cell; PM, plasma membrane
BackgroundMorphine is widely used for pain therapy. However, its clinical applications are often limited by the development of antinociceptive tolerance. That is, when a dose of morphine is given repeatedly and selectively for a single condition, it gradually loses its antinociceptive potency (Fields, 2004;Manchikanti and Singh, 2008). Studies over the past few decades have demonstrated the presence of many types of opioid receptor in the nociceptive sensory neurons and their Aδ-and C-fibre terminals in the superficial dorsal horn of the spinal cord (Fields et al., 1980; Moskowitz and Goodman, 1984;Gouarderes et al., 1991;Besse et al., 1992;Mennicken et al., 2003). The μ-and δ-opioid receptors are predominantly found to be expressed in small-diameter neurons of the dorsal root ganglion (DRG). These small DRG neurons convey the signals from peripheral nociceptors, thermoreceptors and sensitive mechanoreceptors to the superficial dorsal horn of spinal cord, and cause the release of the excitatory neurotransmitter glutamate, as well as the neuropeptides substance P and calcitonin gene-related peptide (CGRP), from the afferent terminals. This excitatory neurotransmission can be presynaptically inhibited by activating μ-or δ-opioid receptors (Ueda et al., 1995;Zachariou and Goldstein, 1996;Beaudry et al., 2011). Therefore, it is of interest to explore the molecular and cellular mechanisms that regulate opioid analgesia and tolerance. The present review discusses the expression, intracellular trafficking and interaction of opioid recept...